The authors used data from pregnant adults enrolled in a randomized trial of a technology-delivered brief motivational intervention addressing sexually transmitted infection risk behaviors, including substance use.

This paper reports secondary analyses relating four motivation subscales to self-reported cannabis use at baseline, 2 months, and 6 months.

Of 176 participants, 62 reported cannabis use during pregnancy. Higher autonomous, introjected, and amotivation scores were associated with lower odds of cannabis use after adjustment for age and marital status.

Higher autonomous, introjected, and external regulation scores were associated with fewer average cannabis-use days. The differing pattern across subscales and outcomes argues for careful interpretation rather than a single simple motivation effect.

Participants were enrolled in a randomized trial, but this analysis did not randomize people to higher or lower motivation. Motivation may reflect other factors that also influence use, including symptoms, social support, perceived risk, access to care, or readiness to change.

The abstract does not report a randomized between-group cannabis outcome for the motivational intervention. The analysis therefore cannot show that the intervention caused reduced cannabis use.

Motivation measures may help clinicians understand whether change is driven by personal goals, internal pressure, external expectations, or uncertainty. Those distinctions can shape how a conversation is framed.

Because stigma can discourage disclosure and care engagement, counseling should support honest reporting, shared planning, and evidence-based discussion of pregnancy-related risk without punishment or shame.

A stronger causal test would prespecify cannabis outcomes, compare randomized intervention groups, verify exposure with appropriate measures, and report retention, missing data, adherence, and adverse outcomes.

Larger and more diverse samples could also test whether motivation predicts change similarly across clinical, socioeconomic, and cultural contexts.

Pregnancy-related cannabis use can involve nausea, pain, sleep, anxiety, dependence, access barriers, and fear of judgment. A useful assessment needs to distinguish these contexts rather than treating every report of use as the same problem.

Professional guidance generally recommends avoiding cannabis during pregnancy because safety has not been established and observational evidence raises concern, while also emphasizing counseling and treatment access rather than stigma.

The most useful feature of this study is its focus on why a person might want to change, not merely whether cannabis use is present.

Motivation can inform the conversation, but it should not be mistaken for a causal treatment mechanism. Patients need clear evidence, practical alternatives for symptoms, and support that keeps them engaged in care.

A Four-Step Reading Frame